Literature DB >> 1932936

Risk factors for developing non-insulin dependent diabetes: a 10 year follow up of men in Uppsala.

E T Skarfors1, K I Selinus, H O Lithell.   

Abstract

OBJECTIVE: To analyse anthropometric and metabolic characteristics as risk factors for development of non-insulin dependent diabetes mellitus in middle aged normoglycaemic men.
DESIGN: Prospective population study based on data collected in a health survey and follow up 10 years later.
SETTING: Uppsala, a middle sized city in Sweden.
SUBJECTS: 2322 men aged 47-53, of whom 1860 attended the follow up 7-14 years later, at which time they were aged 56-64. MAIN OUTCOME MEASURES: Incidence of non-insulin dependent diabetes.
RESULTS: In a multivariate logistic regression analysis, variations of 1 SD from the mean of the group that remained euglycaemic were used to calculate odds ratios and 95% confidence intervals. Blood glucose concentration 60 minutes after the start of an intravenous glucose tolerance test (odds ratio = 5.93, 95% confidence interval 3.05 to 11.5), fasting serum insulin concentration (2.12, 1.54 to 2.93), acute insulin increment at an intravenous glucose tolerance test (1.71, 1.21 to 2.43), body mass index (1.41, 1.01 to 1.97), and systolic blood pressure (1.23, 0.97 to 1.56) were independent predictors of diabetes. In addition, the use of antihypertensive drugs at follow up (selective or unselective beta blocking agents, thiazides, or hydralazine) was an independent risk factor (1.70, 1.11 to 2.60).
CONCLUSIONS: Metabolic and anthropometric characteristics associated with or reflecting insulin resistance as well as a poor acute insulin response to glucose challenge were important predictors of future diabetes in middle aged men. Antihypertensive drugs were found to constitute a further, iatrogenic risk factor.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1932936      PMCID: PMC1670998          DOI: 10.1136/bmj.303.6805.755

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  33 in total

1.  Statistical analysis of the reproducibility of the intravenous glucose tolerance test and the serum insulin response to this test in the middle-aged men.

Authors:  H Hedstrand; J Boberg
Journal:  Scand J Clin Lab Invest       Date:  1975-07       Impact factor: 1.713

2.  Prospective study of 352 young patients with chemical diabetes.

Authors:  J B O'Sullivan; C M Mahan
Journal:  N Engl J Med       Date:  1968-05-09       Impact factor: 91.245

3.  The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus.

Authors:  E Cerasi; R Luft
Journal:  Acta Endocrinol (Copenh)       Date:  1967-06

4.  Reliability of a self-administered medical questionnaire.

Authors:  M F Collen; J L Cutler; A B Siegelaub; R L Cella
Journal:  Arch Intern Med       Date:  1969-06

5.  Diabetes in patients with hypertension receiving pharmacological treatment.

Authors:  H Lundgren; L Björkman; P Keiding; S Lundmark; C Bengtsson
Journal:  BMJ       Date:  1988-12-10

6.  A simplified method using somatostatin to assess in vivo insulin resistance over a range of obesity.

Authors:  M Nagulesparan; P J Savage; R H Unger; P H Bennett
Journal:  Diabetes       Date:  1979-11       Impact factor: 9.461

7.  The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man.

Authors:  R A DeFronzo; C R Cooke; R Andres; G R Faloona; P J Davis
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

8.  The early serum insulin response to intravenous glucose in patients with decreased glucose tolerance and in subjects with a familial history of diabetes mellitus.

Authors:  J Boberg; H Hedstrand; L Wide
Journal:  Scand J Clin Lab Invest       Date:  1976-03       Impact factor: 1.713

9.  Oral glucose-tolerance tests and the diagnosis of diabetes: results of a prospective study based on the Whitehall survey.

Authors:  H A Sayegh; R J Jarrett
Journal:  Lancet       Date:  1979-09-01       Impact factor: 79.321

10.  Diabetes incidence in Pima indians: contributions of obesity and parental diabetes.

Authors:  W C Knowler; D J Pettitt; P J Savage; P H Bennett
Journal:  Am J Epidemiol       Date:  1981-02       Impact factor: 4.897

View more
  40 in total

1.  Can confounding by sociodemographic and behavioural factors explain the association between size at birth and blood pressure at age 50 in Sweden?

Authors:  I Koupilová; D A Leon; D Vågerö
Journal:  J Epidemiol Community Health       Date:  1997-02       Impact factor: 3.710

2.  Predicting impaired glucose metabolism in women with polycystic ovary syndrome by decision tree modelling.

Authors:  M Möhlig; A Flöter; J Spranger; M O Weickert; T Schill; H W Schlösser; G Brabant; A F H Pfeiffer; J Selbig; C Schöfl
Journal:  Diabetologia       Date:  2006-09-14       Impact factor: 10.122

3.  Hypertension and non-insulin dependent diabetes.

Authors:  J S Yudkin
Journal:  BMJ       Date:  1991-09-28

4.  Increase in muscle nerve sympathetic activity after glucose intake is blunted in the elderly.

Authors:  J Fagius; K Ellerfelt; H Lithell; C Berne
Journal:  Clin Auton Res       Date:  1996-08       Impact factor: 4.435

Review 5.  Role of insulin resistance in the pathogenesis of NIDDM.

Authors:  H Yki-Järvinen
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

Review 6.  Progression from IGT to type 2 diabetes mellitus: the central role of impaired early insulin secretion.

Authors:  Richard E Pratley; Christian Weyer
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

Review 7.  Differential effects of antihypertensive drugs on new-onset diabetes?

Authors:  William J Elliott
Journal:  Curr Hypertens Rep       Date:  2005-08       Impact factor: 5.369

8.  Diabetes mellitus and raised serum triglyceride concentration in treated hypertension--are they of prognostic importance? Observational study.

Authors:  O Samuelsson; K Pennert; O Andersson; G Berglund; T Hedner; B Persson; H Wedel; L Wilhelmsen
Journal:  BMJ       Date:  1996-09-14

Review 9.  Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods?

Authors:  L C Groop; E Widén; E Ferrannini
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

10.  Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial.

Authors:  Søren S Lund; Lise Tarnow; Merete Frandsen; Bente B Nielsen; Birgitte V Hansen; Oluf Pedersen; Hans-Henrik Parving; Allan A Vaag
Journal:  BMJ       Date:  2009-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.